Published in Mt Sinai J Med on January 31, 1972
Cellular immune response to acetylcholine receptor-rich fraction, in patients with myasthenia gravis. Clin Exp Immunol (1975) 1.59
Immunological relationship between acetylcholine receptor and thymus: a possible significance in myasthenia gravis. Proc Natl Acad Sci U S A (1975) 1.03
Delayed hypersensitivity to muscle and thymus in myasthenia gravis and polymyositis. Clin Exp Immunol (1974) 0.96
Studies in myasthenia gravis. Heat stability and species specificity of active muscle antigens. Immunology (1973) 0.80
Myasthenia gravis after 300 years: continued search. Calif Med (1973) 0.75
Detection of anti-acetylcholine receptor factors in serum and thymus from patients with myasthenia gravis. N Engl J Med (1976) 1.25
Tumor-associated (CEA-reacting) antigen in patients with inflammatory bowel disease. N Engl J Med (1972) 1.18
Effects of thymectomy in myasthenia gravis. Ann Surg (1987) 1.05
Comparison of the results of the transcervical and transsternal thymectomy in myasthenia gravis. Ann N Y Acad Sci (1981) 1.04
Myasthenia gravis. Cellular response to basic myelin protein compared with cellular and humoral immunity to muscle antigens. Neurology (1973) 0.97
Immunotherapy of the Dunning leukaemia with thymic extracts. Br J Cancer (1973) 0.96
Studies in myasthenia gravis: cellular hypersensitivity to skeletal muscle. Am J Clin Pathol (1972) 0.96
Thymectomy in myasthenia gravis: pathologic, clinical, and electrophysiologic correlations. Ann N Y Acad Sci (1976) 0.95
Calcitonin and carcinoembryonic antigen as tumor markers in medullary thyroid carcinoma. Am J Clin Pathol (1978) 0.93
Transcervical thymectomy in myasthenia gravis. Surg Gynecol Obstet (1975) 0.93
Acetylcholine receptor antibodies in myasthenia gravis. Muscle Nerve (1981) 0.91
Relationship of carcinoembryonic antigen to blood substances A and i: evidence that the antigenic sites are on different molecules. J Immunol (1974) 0.91
Carcinoembryonic antigen (CEA): separation of CEA-reacting molecules from tumor, fetal gut, meconium and normal colon. Immunol Commun (1973) 0.90
Complete duplication of the uterus and cervix with a unilaterally imperforate vagina. Obstet Gynecol (1982) 0.90
The use of ACTH and corticosteroids in myasthenia gravis. Ann N Y Acad Sci (1971) 0.89
Circulating carcinoembryonic antigen (CEA): relationship to clinical status of patients with inflammatory bowel disease. Gut (1973) 0.89
Partial vaginal agenesis with a urinary-vaginal fistula. Obstet Gynecol (1981) 0.87
IgA: presence in meconium obtained from patients with cystic fibrosis. Pediatrics (1971) 0.87
Carcinoembryonic antigen as a tissue marker in medullary thyroid carcinoma. N Engl J Med (1978) 0.87
Chemical analysis of ejaculates from patients with cystic fibrosis. Fertil Steril (1970) 0.87
Treatment of hypertension with spironolactone. Double-blind study. JAMA (1966) 0.87
Metabolism of 14C-labeled pyridostigmine in myasthenia gravis. Evidence for multiple metabolites. Neurology (1970) 0.86
Leukocyte response to muscle antigens in myasthenia gravis. Relationship to clinical severity and presence of circulating antibodies. Neurology (1973) 0.85
Thymectomy in patients more than forty years of age with myasthenia gravis. Surg Gynecol Obstet (1978) 0.84
Carcinoembryonic antigen (CEA) "fingerprints". Br J Cancer (1973) 0.83
Partial purification of pemphigus-related epidermal antigens. J Invest Dermatol (1978) 0.82
The association of carcinoembryonic antigen and peripheral lymphocytes. Surgery (1975) 0.82
Asymmetric hyperthecosis ovarii. Obstet Gynecol (1981) 0.82
Regional curare test in evaluation of ocular myasthenia. Arch Neurol (1975) 0.81
Studies in myasthenia gravis. Incidence of muscle-precipitating antibodies correlated with positive immunofluorescence. Am J Clin Pathol (1969) 0.81
Myasthenia gravis unmasked by antiarrhythmic agents. Mt Sinai J Med (1976) 0.80
Studies in myasthenia gravis. Heat stability and species specificity of active muscle antigens. Immunology (1973) 0.80
Carcinoembryonic antigen (CEA): activity of meconium and normal colon extracts. Immunol Commun (1973) 0.79
Plasmapheresis in refractory generalized myasthenia gravis. Arch Neurol (1981) 0.79
Quantitative determination of water-soluble proteins in meconium. Pediatrics (1970) 0.79
Clinical experience in more than 2000 patients with myasthenia gravis. Ann N Y Acad Sci (1987) 0.78
Proceedings: Phase-specific oncocolon antigens: a theoretical framework for "carcinoembryonic antigen" specificities. Cancer Res (1974) 0.78
Steroid therapy in myasthenia gravis associated with thymoma. Mt Sinai J Med (1978) 0.78
Intercellular antibodies: presence in a Trichophyton rubrum infection. J Invest Dermatol (1972) 0.77
Studies in myasthenia gravis. Pyridostigmine-C14 metabolism after thymectomy. Neurology (1975) 0.76
Myasthenia gravis: migration inhibition of leucocytes in the presence of central-nervous-tissue antigen and muscle antigens. Lancet (1971) 0.76
Plasmapheresis in myasthenia gravis: controlled study. Lancet (1979) 0.76
Thymomas in patients with myasthenia gravis. Ann Surg (1978) 0.76
Exacerbations of myasthenia gravis after removal of thymoma. Acta Neurol Scand (1995) 0.75
Hymenolepis nana: immunogenic exoantigen from mice. Immunology (1972) 0.75
Azathioprine experience in severe, generalized, recalcitrant myasthenia gravis. Mt Sinai J Med (1985) 0.75
Electrophysiologic evaluations of thymectomy in myasthenia gravis. Preliminary findings. Neurology (1976) 0.75
Case report: Thymectomy-induced remission of acquired autoimmune hemolytic anemia in an adult with myasthenia gravis. Am J Med Sci (1979) 0.75
Peripheral ossifying fibroma: report of case. J Oral Surg (1973) 0.75
Use of beta-human chorionic gonadotropin in gestational aging. Ann Clin Lab Sci (1985) 0.75
The emerging role of carcinodevelopmental antigens in the clinical laboratory. Am J Med Technol (1978) 0.75
Rabbit antilymphocyte and antithymocyte serum pools prepared to 1,5-difluoro-2,4-dinitrobenzene-treated cells. Transplantation (1973) 0.75
Letter: HL-A antigens in myasthenia gravis. Lancet (1974) 0.75
Transcervical thymectomy for thymoma in myasthenia gravis. Am J Surg (1982) 0.75
Multiple forms of anti-acetylcholine, receptor antibody in myasthenia gravis. Ann N Y Acad Sci (1981) 0.75
Relationship between plaque mineralization in vitro and calculus formation in vivo. J Dent Res (1973) 0.75
Unilateral ptosis as an initial manifestation of D-penicillamine induced myasthenia gravis. J Rheumatol (1993) 0.75
Electrophysiologic diagnosis of myasthenia gravis and the regional curare test. Neurology (1976) 0.75
Purification of peroxidase by isoelectric focusing. Use of ultrastructural localization of immunoglobulins. Immunochemistry (1976) 0.75
Isolation, chemical characterization, and relative tissue specificity of rat lymphocyte antigens. J Reticuloendothel Soc (1972) 0.75
Thymus and breast cancer--plasma androgens, thymic pathology, and peripheral lymphocytes in myasthenia gravis. J Natl Cancer Inst (1977) 0.75
Pyridostigmine levels in myasthenia gravis. Neurology (1977) 0.75
Relation of glucose to alpha-fetoprotein in amniotic fluid. Obstet Gynecol (1981) 0.75
Effects of myasthenic sera on cultured muscle. Exp Neurol (1976) 0.75
Pleomorphic adenoma, "mixed tumor," minor salivary gland of the palate. Case report. Dent Dig (1969) 0.75
Analysis of false negative results in the immunoassay for anti-acetylcholine receptor antibodies in myasthenia gravis. Clin Immunol Immunopathol (1984) 0.75
The effect of chronic pyridostigmine administration on pyridostigmine-14C metabolism in myasthenia gravis. Neurology (1971) 0.75
Adenocarcinoma of intra-oral minor salivary gland. Case report. N Y State Dent J (1968) 0.75
Comparison of cea-roche "indirect" and "direct" radioimmunoassays: a second look. N Engl J Med (1976) 0.75
Role of calcium in myasthenia gravis. Arch Neurol (1969) 0.75
Case report of Fordyce spots. N Y State Dent J (1966) 0.75
A new method for the production of rabbit antirat lymphocyte serum. Transplantation (1969) 0.75
Prognosis in occult thymomas in myasthenia gravis following transcervical thymectomy. Arch Surg (1987) 0.75
Thymectomy for myasthenia gravis. N Engl J Med (1978) 0.75
Current concepts in myasthenia gravis. J Med Soc N J (1974) 0.75
Myasthenia gravis: association with chronic lymphocytic leukemia. N Y State J Med (1977) 0.75
Multiple forms of anti-acetylcholine receptor antibody in myasthenia gravis. Muscle Nerve (1981) 0.75
Complement fixation for study of placental-type alkaline phosphatase. J Immunol Methods (1979) 0.75
Histaminase and other tumor markers in malignant effusion fluids. Cancer Res (1979) 0.75
A simplified technique in the use of self-polymerizing acrylics for relines and repairs. Dent Dig (1968) 0.75
Gene activation of molecules with carcinoembryonic antigen determinants in fetal development and in adenocarcinoma of the colon. Cancer Res (1976) 0.75
Rabbit anti-rat lymphocyte serum: relationship between dosages, circulating lymphocytes, and the primary immune response. Transplantation (1968) 0.75
Studies in myasthenia gravis: active antigenic sites related to humoral antibody induction. J Immunol (1973) 0.75